logo Click here for the Chao Family Comprehensive Cancer Center Home Page Click here for the UC Irvine Home Page

The Sue and Ralph Stern Center for Cancer Clinical Trials and Research

The Sue and Ralph Stern Center for Cancer Clinical Trials and Research  provides centralized management and oversight functions for coordinating, facilitating and reporting on the cancer clinical trials of the Chao Family Comprehensive Cancer Center (CFCCC).  Specifi­cally, the objectives of the office are to:

  • Facilitate protocol activation and give protocol support to cancer-related research studies
  • Facilitate training of relevant clinicians and research staff regarding protocol parameters
  • Facilitate protocol management and conduct of therapeutic, prevention and intervention trials
  • Promote awareness and facilitate dissemination of information about active clinical trials to cancer center healthcare providers and investigators
  • Facilitate screening/enrollment of potential candidates onto clinical trials
  • Provide central informatics services and accurate reporting for cancer center clinical research protocols
  • Generate an adequate protocol portfolio targeting the existing patient population and prioritizing by protocol type (investigator initiated, national cooperative groups and industry sponsored)
  • Perform quality assurance, research compliance and adherence to GCP through internal or external auditing and monitoring as appropriate
  • Comply with mandatory protocol listing/reporting to the general public

Learn how the cancer center's clinical trials research efforts are being enhanced by a $5-million gift from Orange County philanthropists Sue and Ralph Stern ›

Services Provided

  • Supports protocol activation including submission for Clinical Research Advisory Council (CRAC), Protocol Review Monitoring Committee (PRMC) and IRB review
  • Supports training of relevant clinicians and personnel regarding protocol parameters
  • Informed consent process
  • Eligibility verifi­cation
  • Registration and randomization
  • Coordination of all required interventions throughout subject enrollment, (either therapeutic, preventative or intervention trials)
  • Ensures drug accountability through research pharmacists
  • Coordinates study procedures with clinic nurses
  • Accurate recording and reporting of clinical outcome and toxicity in OnCore
  • Preparation and assistance of internal and external monitoring, as well as internal and external reporting for CCSG compliance and internal strategic planning
  • The office management team facilitates analysis and decision making at different levels of protocol review and prepares technical support for Disease Oriented Teams

Further Information

Interim Senior Manager: Janis DeJohn
Phone: 714 456-6056

Regulatory Affairs Specialist: Cynthia Mann
Phone: 714 456-6472